Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

Launched by UNIVERSITY OF COLORADO, DENVER · Aug 29, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on finding a better way to identify sexual dysfunction in young adults and adolescents who have survived childhood cancer. Researchers want to create a screening method that is easy to use and acceptable for both patients and healthcare providers. By improving how we recognize these issues, the goal is to enhance the overall care and quality of life for young cancer survivors.

To participate in this study, individuals need to be between 15 and 24 years old and must have been diagnosed with cancer before age 18. They should also have received treatment for their cancer, such as chemotherapy, radiation, or surgery. Participants will need to be able to read and speak English and must be attending appointments at specific clinics. Throughout the study, participants can expect to undergo a screening process to evaluate their sexual health. This research aims to make sure that young cancer survivors receive the support they need in this important area of their lives.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• • 1. Provision to sign and date the consent form.
• • 2. Stated willingness to comply with all study procedures and be available for the duration of the study.
• • 3. Be aged 15-24 years old at the time of enrollment
• • 4. Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2)
• 5. Must have received cancer-directed therapy with at least one of the following:
• • Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy
• • Radiotherapy: any radiotherapy to treat the cancer diagnosis
• • Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery.
• • 6. Cancer must have been diagnosed before the age of 18 years
• • 7. Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program
• • Exclusion Criteria
• An individual who meets any of the following criteria will be excluded from participation in this study:
• • 1. Unable to read and speak English
• • 2. Patients who did not receive cancer-directed therapy
• • 3. Insufficient cognitive functioning to complete study measures, as determined by patient's
• • 4. Participation in intervention development
• • 5. Patient is at end of life or on hospice, as determined by primary oncologist
• • 6. Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement
• • 7. Patient is at end of life or on hospice, as determined by primary oncologist